Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that Mr. Jed Latkin, Chief Executive Officer, will present at the LD Micro 500 investor conference. The virtual conference will be held on September 1-4, 2020. Mr. Latkin will present on Tuesday, September 1 at 4:40 p.m. EDT in T
August 24, 2020
· 4 min read